206 related articles for article (PubMed ID: 29063299)
1. Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.
Ryan JF; Groot VP; Rosati LM; Hacker-Prietz A; Narang AK; McNutt TR; Jackson JF; Le DT; Jaffee EM; Zheng L; Laheru DA; He J; Pawlik TM; Weiss MJ; Wolfgang CL; Herman JM
Ann Surg Oncol; 2018 Jan; 25(1):280-289. PubMed ID: 29063299
[TBL] [Abstract][Full Text] [Related]
2. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
[TBL] [Abstract][Full Text] [Related]
3. Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study.
Comito T; Cozzi L; Zerbi A; Franzese C; Clerici E; Tozzi A; Iftode C; Navarria P; D'Agostino G; Fogliata A; Mancosu P; Tomatis S; Carnaghi C; Personeni N; Santoro A; Scorsetti M
Eur J Surg Oncol; 2017 Apr; 43(4):735-742. PubMed ID: 28131670
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
[TBL] [Abstract][Full Text] [Related]
5. Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT.
Groot VP; van Santvoort HC; Rombouts SJ; Hagendoorn J; Borel Rinkes IH; van Vulpen M; Herman JM; Wolfgang CL; Besselink MG; Molenaar IQ
HPB (Oxford); 2017 Feb; 19(2):83-92. PubMed ID: 28065427
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
Simoni N; Micera R; Paiella S; Guariglia S; Zivelonghi E; Malleo G; Rossi G; Addari L; Giuliani T; Pollini T; Cavedon C; Salvia R; Milella M; Bassi C; Mazzarotto R
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e31-e38. PubMed ID: 32682686
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients.
Ryan JF; Rosati LM; Groot VP; Le DT; Zheng L; Laheru DA; Shin EJ; Jackson J; Moore J; Narang AK; Herman JM
Oncotarget; 2018 Mar; 9(23):16427-16436. PubMed ID: 29662656
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
J Gastrointest Oncol; 2022 Jun; 13(3):1402-1412. PubMed ID: 35837183
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer.
Libbey N; Gallagher L; Cantalino J; Weinberg BA; Noel MS; He AR; Radkani P; Marshall JL; Weiner LM; Jackson PG; Fishbein TM; Winslow ER; Haddad N; Rashid A; Unger KR
J Gastrointest Cancer; 2024 Jun; 55(2):852-861. PubMed ID: 38347342
[TBL] [Abstract][Full Text] [Related]
10. Resected pancreatic adenocarcinoma: An Asian institution's experience.
Ng KYY; Chow EWX; Jiang B; Lim C; Goh BKP; Lee SY; Teo JY; Tan DMY; Cheow PC; Ooi LLPJ; Chow PKH; Lee JJX; Kam JH; Koh YX; Jeyaraj PR; Tan EK; Choo SP; Chan CY; Chung AYF; Tai D
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1393. PubMed ID: 33939335
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.
Hill CS; Rosati LM; Hu C; Fu W; Sehgal S; Hacker-Prietz A; Wolfgang CL; Weiss MJ; Burkhart RA; Hruban RH; De Jesus-Acosta A; Le DT; Zheng L; Laheru DA; He J; Narang AK; Herman JM
Ann Surg Oncol; 2022 Apr; 29(4):2456-2468. PubMed ID: 35129721
[TBL] [Abstract][Full Text] [Related]
12. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
14. Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma.
Mizumoto T; Terashima K; Matsuo Y; Nagano F; Demizu Y; Mima M; Sulaiman NS; Tokumaru S; Okimoto T; Toyama H; Fukumoto T
Ann Surg Oncol; 2019 Aug; 26(8):2587-2594. PubMed ID: 31147994
[TBL] [Abstract][Full Text] [Related]
15. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy.
Osipov A; Nissen N; Rutgers J; Dhall D; Naziri J; Chopra S; Li Q; Hendifar AE; Tuli R
Ann Surg Oncol; 2017 Nov; 24(12):3674-3682. PubMed ID: 28871564
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
Chang DT; Schellenberg D; Shen J; Kim J; Goodman KA; Fisher GA; Ford JM; Desser T; Quon A; Koong AC
Cancer; 2009 Feb; 115(3):665-72. PubMed ID: 19117351
[TBL] [Abstract][Full Text] [Related]
17. Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature.
Reddy AV; Sehgal S; Hill CS; Zheng L; He J; Herman JM; Meyer J; Narang AK
Curr Oncol; 2022 Jan; 29(1):308-320. PubMed ID: 35049702
[TBL] [Abstract][Full Text] [Related]
18. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
19. The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
Moningi S; Dholakia AS; Raman SP; Blackford A; Cameron JL; Le DT; De Jesus-Acosta AM; Hacker-Prietz A; Rosati LM; Assadi RK; Dipasquale S; Pawlik TM; Zheng L; Weiss MJ; Laheru DA; Wolfgang CL; Herman JM
Ann Surg Oncol; 2015 Jul; 22(7):2352-8. PubMed ID: 25564157
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins.
Rwigema JC; Heron DE; Parikh SD; Zeh HJ; Moser JA; Bahary N; Ashby K; Burton SA
J Gastrointest Cancer; 2012 Mar; 43(1):70-6. PubMed ID: 20809393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]